WOBURN, Mass. , Sept. 01, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Jonathan "Breck" Harmel as National Director of Sales, Neuromodulation. Mr. Harmel will be responsible for leading the sales organization for the Company's prescription wearable
Inaugural initiative of AARP and MedCity News showcases companies and people delivering cutting-edge healthcare solutions for the 50+ market MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it was selected as one of the healthcare industry's 50+
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) reported today that it had reached the 10th anniversary of its initial listing on NASDAQ. NeuroMetrix debuted on NASDAQ on July 22, 2004 as a medical device company with unique technology that allowed nerve conduction studies,
NeuroMetrix Launches www.SENSUSRx.com WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 22, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced the launch of www.SENSUS Rx .com .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq:NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced the launch of www.DPNCheck.com . The website is an important online resource that will
NeuroMetrix Launches Website for SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that is
Blog to serve as a resource on issues and topics related to chronic pain, such as digital medicine and alternative treatments WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc . (Nasdaq: NURO) today announced the launch of LivingQuell , a blog that will serve as an online resource for people
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq:NURO), an innovative health care company that develops wearable medical technology and point-of-care diagnostics that help patients and physicians better manage chronic pain, nerve disorders, and associated sleep
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that industry insiders got their first look at Quell during day 1 of this year's International Consumer Electronics Show (CES). Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to
The Only FDA Cleared Wearable for 24/7 Chronic Pain Relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the full commercial launch of Quell , which is now available on the Company's product website at QuellRelief.com and at select physicians' offices.
